Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers

NCT04484532 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Myelodysplastic Syndrome

Interventions

BIOLOGICAL: Trivalent Influenza Vaccine

Sponsor

Roswell Park Cancer Institute